OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences
OTR Acquisition Corp. Reports Filed Confidential Submission Of S-4 Registration Statement Related To SPAC Deal With Comera Life Sciences
OTR Acquisition Corp. (NASDAQ:OTRAU, OTRA and OTRAW))), a publicly traded special purpose acquisition company (SPAC), today announced the confidential submission with the U.S. Securities and Exchange Commission ("SEC") of a draft registration statement on Form S-4 (the "Registration Statement") relating to its previously announced proposed business combination with Comera Life Sciences, Inc.
Otr Acquisition Corp.(纳斯达克代码:OTRAU,OTRA and OTRAW)是一家上市的特殊目的收购公司(SPAC),今天宣布向美国证券交易委员会(“美国证券交易委员会”)保密提交一份S-4表格注册声明草案(下称“注册声明”),涉及其先前宣布的与Comera生命科学公司拟议的业务合并。
This press release features multimedia. View the full release here:
这份新闻稿以多媒体为特色。点击此处查看完整版本:
In addition, the investor call with Comera and OTR has been rescheduled to Tuesday, Feb. 8 at 8:30 a.m. EST (from previous date and time of Friday, Feb. 4 at 8:30 a.m. EST) to discuss the proposed business combination. An audio webcast of the event will be available on the OTR Investor Relations website at
此外,与Comera和OTR的投资者电话会议已重新安排到2月8日星期二上午8:30。东部时间(来自之前的日期和时间,2月4日,星期五,上午8:30EST(EST:行情)讨论拟议的业务合并.此次活动的音频网络直播将在OTR投资者关系网站上提供,网址为:
译文内容由第三方软件翻译。